CORESTEM Inc (166480) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.103x

Based on the latest financial reports, CORESTEM Inc (166480) has a cash flow conversion efficiency ratio of -0.103x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-4.18 Billion ≈ $-2.83 Million USD) by net assets (₩40.62 Billion ≈ $27.53 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See how many days can CORESTEM Inc fund operations to measure how many days the company can operate on defensive assets alone.

CORESTEM Inc - Cash Flow Conversion Efficiency Trend (2014–2024)

This chart illustrates how CORESTEM Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data.

CORESTEM Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of CORESTEM Inc ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
NetSol Technologies Inc NASDAQ:NTWK	-0.113x
HBR Realty Empreendimentos Imobiliários S.A SA:HBRE3	0.065x
Idex ASA OL:IDEX	-0.972x
Banswara Syntex Limited NSE:BANSWRAS	0.035x
Strongpoint ASA OL:STRO	0.061x
360 Capital Group AU:TGP	0.011x
DIC India Limited NSE:DICIND	0.099x
York Timber Holdings Ltd JSE:YRK	0.024x

Annual Cash Flow Conversion Efficiency for CORESTEM Inc (2014–2024)

The table below shows the annual cash flow conversion efficiency of CORESTEM Inc from 2014 to 2024. For the full company profile with market capitalisation and key ratios, see market value of CORESTEM Inc.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	₩48.59 Billion ≈ $32.93 Million	₩-21.12 Billion ≈ $-14.31 Million	-0.435x	+45.73%
2023-12-31	₩19.60 Billion ≈ $13.28 Million	₩-15.70 Billion ≈ $-10.64 Million	-0.801x	-294.34%
2022-12-31	₩41.46 Billion ≈ $28.10 Million	₩-8.42 Billion ≈ $-5.71 Million	-0.203x	+1.23%
2021-12-31	₩37.19 Billion ≈ $25.20 Million	₩-7.65 Billion ≈ $-5.18 Million	-0.206x	-290.05%
2020-12-31	₩41.29 Billion ≈ $27.98 Million	₩4.47 Billion ≈ $3.03 Million	0.108x	+1260.00%
2019-12-31	₩57.70 Billion ≈ $39.10 Million	₩-538.08 Million ≈ $-364.65K	-0.009x	+48.55%
2018-12-31	₩62.24 Billion ≈ $42.18 Million	₩-1.13 Billion ≈ $-764.48K	-0.018x	+81.10%
2017-12-31	₩65.60 Billion ≈ $44.46 Million	₩-6.29 Billion ≈ $-4.26 Million	-0.096x	-282.69%
2016-12-31	₩66.73 Billion ≈ $45.22 Million	₩3.50 Billion ≈ $2.37 Million	0.053x	+424.60%
2015-12-31	₩63.04 Billion ≈ $42.72 Million	₩-1.02 Billion ≈ $-691.01K	-0.016x	+87.47%
2014-12-31	₩18.97 Billion ≈ $12.86 Million	₩-2.45 Billion ≈ $-1.66 Million	-0.129x	--

About CORESTEM Inc

KQ:166480 Korea Biotechnology

Market Cap

$49.69 Million

₩73.33 Billion KRW

Market Cap Rank

#21975 Global

#1334 in Korea

Share Price

₩2610.00

Change (1 day)

-2.06%

52-Week Range

₩1060.00 - ₩4800.00

All Time High

₩32150.00